Hardy Reed’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-2,570
Closed -$247K – 271
2026
Q2
$247K Buy
2,570
+245
+11% +$25.1K 0.02% 220
2026
Q1
$254K Buy
+2,325
New +$222K 0.02% 212

Other funds holding LMAT

Hardy Reed's LMAT Position: Q3 2026 in Review

Hardy Reed sold out of LeMaitre Vascular (LMAT) in Q3 2026, closing a stake of 2,570 shares — an estimated $247K sold.

Hardy Reed first reported a position in LMAT in Q1 2026 and held it in 2 quarters. The position peaked at $254K in Q1 2026. 298 funds tracked by Wall St. Rank hold LMAT as of Q3 2026.

  • Hardy Reed reported no remaining LeMaitre Vascular position as of Q3 2026 after selling out during the quarter.
  • Hardy Reed sold 2,570 LeMaitre Vascular shares in Q3 2026, an estimated $247K.
  • Hardy Reed first reported a position in LeMaitre Vascular in Q1 2026 and held it in 2 quarters.
  • Hardy Reed's LeMaitre Vascular position peaked at $254K in Q1 2026.
  • 298 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q3 2026.

Based on Hardy Reed's 13F filing for Q3 2026, filed 6 Nov 2026.